See more : Simonds Group Limited (SIO.AX) Income Statement Analysis – Financial Results
Complete financial analysis of GemVax&KAEL Co.,Ltd (082270.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GemVax&KAEL Co.,Ltd, a leading company in the industry within the sector.
You may be interested
- Future Bright Mining Holdings Limited (2212.HK) Income Statement Analysis – Financial Results
- INTOSOL Holdings PLC (INTO.L) Income Statement Analysis – Financial Results
- Belships ASA (NS6.F) Income Statement Analysis – Financial Results
- Vivesto AB (0N4A.L) Income Statement Analysis – Financial Results
- QcX Gold Corp. (QCXGF) Income Statement Analysis – Financial Results
GemVax&KAEL Co.,Ltd (082270.KQ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 72.21B | 75.80B | 60.37B | 65.66B | 42.66B |
| Cost of Revenue | 46.16B | 53.94B | 41.49B | 40.12B | 28.13B |
| Gross Profit | 26.05B | 21.86B | 18.88B | 25.55B | 14.54B |
| Gross Profit Ratio | 36.07% | 28.84% | 31.27% | 38.91% | 34.07% |
| Research & Development | 15.67B | 11.63B | 7.24B | 4.51B | 4.95B |
| General & Administrative | 1.08B | 867.59M | 1.02B | 1.08B | 112.79M |
| Selling & Marketing | 4.09B | 2.86B | 3.58B | 2.87B | 2.46B |
| SG&A | 5.17B | 3.72B | 4.60B | 3.95B | 15.52B |
| Other Expenses | 13.08B | 53.51M | -673.57M | -989.39M | 0.00 |
| Operating Expenses | 33.92B | 25.43B | 21.33B | 24.11B | 106.11B |
| Cost & Expenses | 80.08B | 79.38B | 62.82B | 64.23B | 134.24B |
| Interest Income | 294.97M | 170.17M | 272.83M | 894.89M | 0.00 |
| Interest Expense | 462.86M | 445.31M | 404.96M | 1.23B | 3.21B |
| Depreciation & Amortization | 3.99B | 3.04B | 2.31B | 1.72B | 1.68B |
| EBITDA | -22.89B | -6.22B | -135.45M | 1.68B | -5.90B |
| EBITDA Ratio | -31.71% | -8.20% | 21.04% | 19.49% | -13.82% |
| Operating Income | -7.87B | -3.95B | -3.63B | 1.44B | -7.58B |
| Operating Income Ratio | -10.90% | -5.20% | -6.01% | 2.19% | -17.76% |
| Total Other Income/Expenses | -19.48B | -15.66B | 15.69B | 176.55M | -87.21B |
| Income Before Tax | -27.35B | -19.60B | 12.06B | 1.64B | -94.79B |
| Income Before Tax Ratio | -37.87% | -25.86% | 19.97% | 2.49% | -222.17% |
| Income Tax Expense | -170.87M | -5.31B | 14.01B | 9.64B | 0.00 |
| Net Income | -27.18B | -19.60B | 12.06B | 1.64B | -94.79B |
| Net Income Ratio | -37.64% | -25.86% | 19.97% | 2.49% | -222.17% |
| EPS | -691.00 | -497.00 | 304.00 | 42.00 | -2.64K |
| EPS Diluted | -690.62 | -515.00 | 280.00 | -162.00 | -2.64K |
| Weighted Avg Shares Out | 39.33M | 39.44M | 39.67M | 38.93M | 35.96M |
| Weighted Avg Shares Out (Dil) | 39.35M | 38.07M | 39.86M | 39.66M | 35.96M |
No news found for: 082270.KQ
Source: https://incomestatements.info
Category: Stock Reports